1. Methodological issues in antiemetic studies

   • Matti Aapro

   Review Pages: 243 - 253

2. Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the Rhesus monkey

   • Stacey L. Berg
   • Frank M. Balis
   • David G. Poplack

   Preclinical Studies Pages: 255 - 261

3. Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice

   • Marie-Christine Bissery
   • Chi Hung Nguyen
   • François Lavelle

   Preclinical Studies Pages: 263 - 277

4. Effects of diflubenzuron and clanfenur on mouse bone marrow cells

   • Vernon K. Jenkins
   • Harinder S. Juneja
   • Robert R. Perry

   Preclinical Studies Pages: 279 - 289

5. Phase I trial of mitoxantrone and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced solid malignancies

   • Joan H. Schiller
   • Barry Storer
   • David Spriggs

   Phase I Clinical Trials Pages: 291 - 300

6. Phase I pharmacokinetic study of DUP-937, a new anthrapyrazole

   • Karl Bélanger
   • Jacques Jolivet
   • Elizabeth Eisenhauer

   Phase I Clinical Trials Pages: 301 - 308

7. A phase I trial of fazarabine in refractory pediatric solid tumors

   • Mark L. Bernstein
   • V. Michael Whitehead
   • Faith Kung

   Phase I Clinical Trials Pages: 309 - 312

8. Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia

   • Constance Mazurek
   • Janice P. Dutcher
   • Peter H. Wiernik

   Phase I Clinical Trials Pages: 313 - 322

9. Phase II trial of LY 186641 in advanced renal cancer

   • Monder Mahjoubi
   • Joseph Kattan
   • Jean-Pierre Droz

   Phase II Clinical Trials Pages: 323 - 328

10. A phase II trial of piroxantrone in adenocarcinoma of the pancreas

    • Terry R. Jenkins
    • Catherine Tangen
    • Alexander Hantel

    Phase II Clinical Trials Pages: 329 - 331

11. VM-26 in gastric cancer

    • Jeffrey L. Berenberg
    • Catherine Tangen
    • Leslie Rogers Laufman

    Phase II Clinical Trials Pages: 333 - 334

12. A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer

    • Vikki A. Canfield
    • Alan P. Lyss

    Phase II Clinical Trials Pages: 335 - 336

13. Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas

    • Mark M. Zalupski
    • Jacqueline Benedetti
    • John Wendall Goodwin

    Phase II Clinical Trials Pages: 337 - 341